Primary Tumor Site Specificity is Preserved in Patient-Derived Tumor Xenograft Models
Patient-derived tumor xenograft (PDX) mouse models are widely used for drug screening. The underlying assumption is that PDX tissue is very similar with the original patient tissue, and it has the same response to the drug treatment. To investigate whether the primary tumor site information is well...
Main Authors: | Lei Chen, Xiaoyong Pan, Yu-Hang Zhang, Xiaohua Hu, KaiYan Feng, Tao Huang, Yu-Dong Cai |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-08-01
|
Series: | Frontiers in Genetics |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fgene.2019.00738/full |
Similar Items
-
Gene Expression Difference Between Primary and Metastatic Renal Cell Carcinoma Using Patient-Derived Xenografts
by: Yang Jiang, et al.
Published: (2019-01-01) -
Identification of Differentially Expressed Genes between Original Breast Cancer and Xenograft Using Machine Learning Algorithms
by: Deling Wang, et al.
Published: (2018-03-01) -
Tumor xenograft animal models for esophageal squamous cell carcinoma
by: Nikki P. Lee, et al.
Published: (2018-08-01) -
Identification of the Gene Expression Rules That Define the Subtypes in Glioma
by: Yu-Dong Cai, et al.
Published: (2018-10-01) -
Establishment and Characterization of Feline Mammary Tumor Patient-Derived Xenograft Model
by: Hsiao-Li Chuang, et al.
Published: (2021-08-01)